Pilot Study of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Cyclophosphamide; Fluorouracil; Methotrexate; Pegfilgrastim
- Indications Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 21 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.